Impinj
PI
191.04
+6.88
+3.74%
Impinj
US · PI
#1959 by market cap
Listed 2016
191.04
+6.88
+3.74%
Live - 5344 symbols - heartbeat 470s ago
· 2026-10-08 06:38
Pre-market
190.01
-0.54%
After-hours
192.30
+0.66%
- Market cap
- 5.84B
- P/E (TTM)i
- -209.93
- P/Bi
- 25.21
- EPSi
- -0.37
- Div yieldi
- 0.00%
- 52W posi
- 65%
Reader sentiment
Are you bullish or bearish on PI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 10.52, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.37% YoY
Margins
- Gross margin
- 52.53%
- Operating margin
- -0.20%
- Net margin
- -3.00%
Key ratios & quality
- Enterprise valuei
- 5.94B
- Altman Z-Scorei
- 10.52
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 122.63M | 152.84M | 138.92M | 190.28M | 257.80M | 307.54M | 366.09M | 361.08M |
| Gross profit | 58.28M | 74.00M | 65.14M | 98.95M | 137.88M | 151.98M | 188.86M | 189.68M |
| Selling & admin expenses | 55.23M | 56.78M | 63.62M | 70.42M | 83.36M | 101.95M | 92.38M | 85.72M |
| Research & development | 34.17M | 38.88M | 48.59M | 64.06M | 74.11M | 88.56M | 98.83M | 102.62M |
| Operating profit | -31.12M | -21.66M | -47.07M | -35.53M | -19.58M | -43.48M | -5.26M | -737.00K |
| Pretax profit | -35.46M | -22.79M | -51.83M | -51.11M | -24.12M | -43.69M | 41.00M | -10.92M |
| Tax | -233.00K | 198.00K | 89.00K | 153.00K | 184.00K | -322.00K | 157.00K | -69.00K |
| Net profit | -35.23M | -22.99M | -51.92M | -51.26M | -24.30M | -43.37M | 40.84M | -10.85M |
| Basic EPS | -2 | -1 | -2 | -2 | -1 | -2 | 1 | 0 |
| Diluted EPS | -1.65 | -1.05 | -2.28 | -2.12 | -0.95 | -1.62 | 1.39 | -0.37 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 74.28M | 97.89M | 96.06M | 92.85M | 74.25M | 108.37M |
| Gross profit | 36.68M | 56.61M | 48.33M | 48.06M | 36.46M | 63.53M |
| Selling & admin expenses | 20.45M | 20.57M | 21.42M | 23.29M | 22.37M | 23.23M |
| Research & development | 25.31M | 24.65M | 25.72M | 26.93M | 28.72M | 29.26M |
| Operating profit | -9.57M | 10.87M | 656.00K | -2.70M | -15.17M | 10.50M |
| Pretax profit | -8.73M | 11.70M | -12.90M | -987.00K | -25.21M | 12.13M |
| Tax | -281.00K | 149.00K | -89.00K | 152.00K | 48.00K | -92.00K |
| Net profit | -8.45M | 11.55M | -12.81M | -1.14M | -25.26M | 12.22M |
| Basic EPS | 0 | 0 | 0 | 0 | -1 | 0 |
| Diluted EPS | -0.30 | 0.39 | -0.44 | -0.04 | -0.83 | 0.39 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 121.21M | 176.77M | 171.36M | 255.80M | 275.17M | 269.70M | 326.40M | 339.22M |
| Cash & ST investments | 56.07M | 116.50M | 106.09M | 193.35M | 173.75M | 113.23M | 164.71M | 175.34M |
| Inventory | 44.73M | 34.15M | 36.33M | 21.96M | 46.40M | 97.17M | 99.35M | 84.96M |
| Total assets | 145.07M | 215.05M | 207.62M | 315.54M | 349.74M | 359.41M | 489.08M | 545.19M |
| Total current liabilities | 23.03M | 19.50M | 27.59M | 35.50M | 42.37M | 30.88M | 331.18M | 126.53M |
| Short-term debt | 7.04M | 3.38M | 3.64M | 13.78M | 3.12M | 3.37M | 287.08M | 97.52M |
| Long-term debt | 17.63M | 50.88M | 54.56M | 278.66M | 280.24M | 281.86M | -- | 184.14M |
| Total liabilities | 47,186,000.00 | 89,807,000.00 | 98,497,000.00 | 326,613,000.00 | 334,146,000.00 | 325,278,000.00 | 339,216,000.00 | 335,955,000.00 |
| Total equity | 97.88M | 125.24M | 109.12M | -11.08M | 15.59M | 34.13M | 149.86M | 209.23M |
| Retained earnings | -239.76M | -262.74M | -314.67M | -362.48M | -386.79M | -430.15M | -389.31M | -400.16M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 308.57M | 349.77M | 351.78M | 339.22M | 299.04M | 304.60M |
| Cash & ST investments | 147.92M | 193.21M | 190.08M | 175.34M | 131.84M | 133.02M |
| Inventory | 98.48M | 96.21M | 92.64M | 84.96M | 86.30M | 91.50M |
| Total assets | 479.83M | 508.82M | 516.46M | 545.19M | 502.52M | 534.75M |
| Total current liabilities | 28.17M | 30.05M | 131.80M | 126.53M | 32.50M | 92.96M |
| Short-term debt | 3.67M | 3.82M | 100.54M | 97.52M | 1.52M | 58.83M |
| Long-term debt | 283.91M | 284.32M | 183.75M | 184.14M | 241.47M | 184.92M |
| Total liabilities | 319,261,000.00 | 321,128,000.00 | 321,496,000.00 | 335,955,000.00 | 298,618,000.00 | 303,163,000.00 |
| Total equity | 160.56M | 187.69M | 194.96M | 209.23M | 203.91M | 231.59M |
| Retained earnings | -397.76M | -386.21M | -399.02M | -400.16M | -425.42M | -413.20M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -11.78M | 4.71M | -16.88M | 6.47M | 641.00K | -49.38M | 128.31M | 58.75M |
| Depreciation & amortization | 4.53M | 4.81M | 4.50M | 4.60M | 6.04M | 13.62M | 13.59M | 15.04M |
| Free cash flow | -18.14M | 2.28M | -19.95M | -9.77M | -11.44M | -68.22M | 111.20M | 45.89M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 17.53M | 66.90M | 23.64M | 123.90M | 19.60M | 94.79M | 46.05M | 48.21M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -11.14M | 33.86M | 20.89M | 15.14M | 3.98M | 31.60M |
| Depreciation & amortization | 3.52M | 3.71M | 3.85M | 3.96M | 3.85M | 3.89M |
| Free cash flow | -13.01M | 27.32M | 17.95M | 13.62M | 2.23M | 29.19M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 61.32M | 42.42M | 51.73M | 48.21M | 32.30M | 38.57M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -32.50 | -20.60 | -44.31 | -104.57 | -1,076.46 | -174.43 | 44.39 | -6.04 |
| ROA %i | -23.72 | -12.77 | -24.57 | -19.60 | -7.31 | -12.23 | 9.63 | -2.10 |
| ROIC %i | -26.75 | -13.48 | -25.20 | -20.94 | -7.19 | -12.57 | 11.42 | -1.63 |
| 5-year avg ROE %i | -- | -- | -30.47 | -43.25 | -255.69 | -284.07 | -271.08 | -263.42 |
| EBIT margin %i | -27.77 | -13.74 | -33.50 | -25.82 | -8.07 | -13.15 | 12.08 | -2.18 |
| FCF / sales %i | -- | 1.49 | -- | -- | -- | -- | 30.37 | 12.71 |
| Current ratioi | 5.26 | 9.07 | 6.21 | 7.21 | 6.49 | 8.73 | 0.99 | 2.68 |
| Quick ratioi | 3.24 | 7.19 | 4.75 | 6.44 | 5.28 | 5.45 | 0.67 | 1.95 |
| Debt / assetsi | 17.18 | 34.02 | 35.38 | 96.46 | 84.19 | 81.96 | 59.87 | 55.80 |
| LT debt / equityi | 18.28 | 55.72 | 63.99 | -- | 1,868.45 | 853.23 | 3.82 | 98.78 |
| Interest coveragei | -24.28 | -11.70 | -8.78 | -24.79 | -6.26 | -12.50 | 13.68 | -2.58 |
| Revenue CAGR (3Y) %i | 16.04 | 10.82 | 3.50 | 15.77 | 19.04 | 30.33 | 24.37 | 11.88 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -1.76 | 0.42 | -7.49 | -6.04 | -15.18 | -12.87 |
| ROA %i | -0.49 | 0.13 | -2.50 | -2.10 | -5.63 | -5.17 |
| ROIC %i | 0.17 | 0.83 | -2.05 | -1.63 | -5.67 | -5.29 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 0.59 | 1.09 | -2.65 | -2.18 | -6.90 | -6.76 |
| FCF / sales %i | 12.17 | 7.65 | 11.33 | 12.71 | 16.93 | 16.95 |
| Current ratioi | 10.96 | 11.64 | 2.67 | 2.68 | 9.20 | 3.28 |
| Quick ratioi | 7.28 | 8.26 | 1.91 | 1.95 | 6.28 | 2.20 |
| Debt / assetsi | 60.93 | 57.47 | 55.67 | 55.80 | 52.75 | 49.87 |
| LT debt / equityi | 179.79 | 153.76 | 95.91 | 98.78 | 129.25 | 89.74 |
| Interest coveragei | 0.67 | 1.21 | -3.08 | -2.58 | -9.95 | -13.56 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
The development and sale of our products and services100.00%
Quote time 2026-10-08 06:38:39 · For reference only, not investment advice and not tailored to your situation.